Specialized Medical Company (TADAWUL:4019)
Saudi Arabia · Delayed Price · Currency is SAR 15.55
-0.32 (-2.02%)
Aug 13, 2026, 3:15 PM AST
TADAWUL:4019 Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,572 | 1,538 | 1,438 | 1,368 | 1,209 | 1,053 | |
Revenue Growth | 7.20% | 7.00% | 5.11% | 13.18% | 14.77% | 21.44% |
Cost of Revenue | 1,187 | 1,157 | 1,077 | 1,019 | 930 | 824.89 |
Gross Profit | 385.7 | 381.59 | 361.06 | 348.96 | 278.66 | 228.24 |
Selling, General & Admin | 143.35 | 146.6 | 130.59 | 134.38 | 150.91 | 159.04 |
Operating Expenses | 143.35 | 146.6 | 130.59 | 134.38 | 150.91 | 159.04 |
Operating Income | 242.35 | 234.99 | 230.47 | 214.58 | 127.75 | 69.2 |
Interest Expense | -39.36 | -42.47 | -45.17 | -48.46 | -29.82 | -18.89 |
Other Non Operating Income (Expenses) | 19.99 | 19.36 | 8.35 | 8.52 | 9.13 | 8.98 |
EBT Excluding Unusual Items | 222.98 | 211.87 | 193.66 | 174.65 | 107.05 | 59.29 |
Gain (Loss) on Sale of Assets | 60.63 | 60.63 | - | 0.05 | 0.06 | - |
Pretax Income | 283.6 | 272.5 | 193.66 | 174.7 | 107.12 | 59.29 |
Income Tax Expense | 5.65 | 6.27 | 8.44 | 6 | 4.15 | 3.32 |
Net Income | 277.95 | 266.23 | 185.22 | 168.7 | 102.96 | 55.97 |
Net Income to Common | 277.95 | 266.23 | 185.22 | 168.7 | 102.96 | 55.97 |
Net Income Growth | 83.99% | 43.74% | 9.79% | 63.84% | 83.97% | 21.62% |
Shares Outstanding (Basic) | 250 | 250 | 250 | 85 | 85 | 85 |
Shares Outstanding (Diluted) | 250 | 250 | 250 | 85 | 85 | 85 |
Shares Change | - | - | 194.12% | - | - | - |
EPS (Basic) | 1.11 | 1.06 | 0.74 | 1.98 | 1.21 | 0.66 |
EPS (Diluted) | 1.11 | 1.06 | 0.74 | 1.98 | 1.21 | 0.66 |
EPS Growth | 83.99% | 43.74% | -62.67% | 63.84% | 83.97% | 21.62% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 317.35 | 228.28 | 289.52 | 160.53 | 116.6 | -159.38 |
Free Cash Flow Per Share | 1.27 | 0.91 | 1.16 | 1.89 | 1.37 | -1.88 |
Dividend Per Share | 0.320 | 0.320 | - | - | - | - |
Dividend Growth | - | - | - | - | - | - |
Gross Margin | 24.53% | 24.80% | 25.11% | 25.51% | 23.05% | 21.67% |
Operating Margin | 15.41% | 15.27% | 16.03% | 15.69% | 10.57% | 6.57% |
Profit Margin | 17.68% | 17.30% | 12.88% | 12.33% | 8.52% | 5.31% |
Free Cash Flow Margin | 20.18% | 14.84% | 20.14% | 11.73% | 9.65% | -15.13% |
EBITDA | 307.15 | 297.44 | 288.94 | 273.08 | 202.59 | 141.55 |
EBITDA Margin | 19.54% | 19.33% | 20.10% | 19.96% | 16.76% | 13.44% |
D&A For EBITDA | 64.8 | 62.46 | 58.47 | 58.49 | 74.85 | 72.35 |
EBIT | 242.35 | 234.99 | 230.47 | 214.58 | 127.75 | 69.2 |
EBIT Margin | 15.41% | 15.27% | 16.03% | 15.69% | 10.57% | 6.57% |
Effective Tax Rate | 1.99% | 2.30% | 4.36% | 3.44% | 3.88% | 5.60% |
Advertising Expenses | - | 15.99 | 8.95 | - | - | - |